Spyre Therapeutics, Inc. · NASDAQ:SYRE

Burrows Scott L sold 7,500 Spyre Therapeutics, Inc. shares (Form 4)

Traded Jul 1, 2026 · Filed Jul 2, 2026

On Jul 1, 2026, Burrows Scott L (Chief Financial Officer) sold 7,500 Spyre Therapeutics, Inc. shares at an average US$87.74 for US$658K under a trading plan, leaving 97,994 shares. Filed Jul 2, 2026 (Form 4).

Sold
7,500 shares
Price
US$87.74 average (US$87.55 to US$88.37)
Value
US$658K
Holding after
97,994 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 1, 2026Common StockOption exercise7,500US$14.50105,494Direct
Jul 1, 2026Common StockSale5,775US$87.5599,719Direct
Jul 1, 2026Common StockSale1,725US$88.3797,994Direct

Source

View original at SEC

Related